Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype

The development of the skeleton requires the coordinated activities of bone-forming osteoblasts and bone-resorbing osteoclasts. The activities of these two cell types are likely to be regulated by TGF-beta, which is abundant in bone matrix. We have used transgenic mice to evaluate the role of TGF-beta 2 in bone development and turnover. Osteoblast- specific overexpression of TGF-beta 2 from the osteocalcin promoter resulted in progressive bone loss associated with increases in osteoblastic matrix deposition and osteoclastic bone resorption. This phenotype closely resembles the bone abnormalities seen in human hyperparathyroidism and osteoporosis. Furthermore, a high level of TGF- beta 2 overexpression resulted in defective bone mineralization and severe hypoplasia of the clavicles, a hallmark of the developmental disease cleidocranial dysplasia. Our results suggest that TGF-beta 2 functions as a local positive regulator of bone remodeling and that alterations in TGF-beta 2 synthesis by bone cells, or in their responsiveness to TGF-beta 2, may contribute to the pathogenesis of metabolic bone disease.

[1]  K. Jones,et al.  Smith's Recognizable Patterns of Human Malformation , 1996 .

[2]  R. Ziegler,et al.  Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. , 1995, The Journal of clinical investigation.

[3]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[4]  Lynda F. Bonewald,et al.  Role of active and latent transforming growth factor β in bone formation , 1994 .

[5]  A. Parfitt.  Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone , 1994, Journal of cellular biochemistry.

[6]  S. Miller,et al.  Systemic administration of recombinant transforming growth factor beta 2 (rTGF-beta 2) stimulates parameters of cancellous bone formation in juvenile and adult rats. , 1994, Bone.

[7]  G. Ciliberto,et al.  Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.

[8]  J. Wozney,et al.  Transforming Growth Factor-β Gene Family Members and Bone* , 1994 .

[9]  L. Bonewald,et al.  Role of active and latent transforming growth factor beta in bone formation. , 1994, Journal of cellular biochemistry.

[10]  S A Goldstein,et al.  Osteoporosis induced in mice by overproduction of interleukin 4. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Allan,et al.  Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells , 1993, Journal of cellular physiology.

[12]  G. Müller,et al.  Reduction of background problems in nonradioactive northern and Southern blot analyses enables higher sensitivity than 32P-based hybridizations. , 1993, Analytical biochemistry.

[13]  S. Nishimoto,et al.  Rapid and sensitive method for quantitation of bone Gla protein mRNA using competitive polymerase chain reaction , 1993 .

[14]  G. Mundy.  Cytokines of Bone , 1993 .

[15]  L. Demers,et al.  Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Taylor,et al.  Osteoblast-specific expression of growth hormone stimulates bone growth in transgenic mice , 1992, Molecular and cellular biology.

[17]  Matthew H. Kaufman,et al.  The Atlas of Mouse Development , 1992 .

[18]  B. Riggs,et al.  Modulation of Transforming Growth Factor-β Production in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone , 1991 .

[19]  H. Moses,et al.  Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development , 1991, The Journal of cell biology.

[20]  M. Rudnicki,et al.  Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.

[21]  S. Mohan,et al.  Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Burger,et al.  Inhibiting and stimulating effects of TGF‐β1 on osteoclastic bone resorption in fetal mouse bone organ cultures , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  F. Singer.  Parathyroid hormone-related protein. , 1990, Mayo Clinic proceedings.

[24]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[25]  F. Bosman,et al.  Histochemical detection of osteocalcin in normal and pathological human bone. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  A. Brunner,et al.  Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. , 1989, The Journal of biological chemistry.

[27]  E. Chen,et al.  Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos. , 1989, Molecular endocrinology.

[28]  M. Noda,et al.  In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.

[29]  B. Hall,et al.  Growth of the clavicle and development of clavicular secondary cartilage in the embryonic mouse. , 1989, Acta anatomica.

[30]  G. Mundy,et al.  Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. , 1988, The Journal of clinical investigation.

[31]  G. Roodman,et al.  Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Canalis,et al.  Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Alitalo,et al.  Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. , 1988, Development.

[34]  B. Haendler,et al.  Complementary DNA for human glioblastoma‐derived T cell suppressor factor, a novel member of the transforming growth factor‐beta gene family. , 1987, The EMBO journal.

[35]  D. Sillence,et al.  Animal model: skeletal anomalies in mice with cleidocranial dysplasia. , 1987, American journal of medical genetics.

[36]  G. Mundy,et al.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Massagué,et al.  Type beta transforming growth factor is an inhibitor of myogenic differentiation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Spizz,et al.  Regulation of myogenic differentiation by type beta transforming growth factor , 1986, The Journal of cell biology.

[39]  B. Hall.  The role of movement and tissue interactions in the development and growth of bone and secondary cartilage in the clavicle of the embryonic chick. , 1986, Journal of embryology and experimental morphology.

[40]  P. McSheehy,et al.  Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. , 1986, Endocrinology.

[41]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[42]  T. Wronski,et al.  Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. , 1986, Bone.

[43]  P. Hauschka,et al.  Light and electron microscopic demonstration of osteocalcin antigenicity in embryonic and adult rat bone. , 1986, Bone.

[44]  D. Lawrence,et al.  Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions , 1985 .

[45]  R. Derynck,et al.  Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Bronckers,et al.  Immunolocalization of γ-Carboxyglutamic Acid Containing Proteins in Developing Rat Bones , 1985 .

[47]  D. Rosen,et al.  Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[48]  W. Murphy,et al.  Postmenopausal osteoporosis: A heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients , 1982 .

[49]  C. Benoist,et al.  Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[50]  E. Weibel.  Stereological principles for morphometry in electron microscopic cytology. , 1969, International review of cytology.

[51]  A. C. Pai,et al.  DEVELOPMENTAL GENETICS OF A LETHAL MUTATION, MUSCULAR DYSGENESIS (MDG), IN THE MOUSE. I. GENETIC ANALYSIS AND GROSS MORPHOLOGY. , 1965, Developmental biology.